(NYSE: COR) Cencora's forecast annual revenue growth rate of 7.3% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.61%.
Cencora's revenue in 2025 is $316,654,371,000.On average, 5 Wall Street analysts forecast COR's revenue for 2026 to be $66,374,302,336,217, with the lowest COR revenue forecast at $65,932,535,686,373, and the highest COR revenue forecast at $66,749,500,627,865. On average, 5 Wall Street analysts forecast COR's revenue for 2027 to be $71,027,078,724,617, with the lowest COR revenue forecast at $70,012,773,243,170, and the highest COR revenue forecast at $71,600,403,924,905.
In 2028, COR is forecast to generate $76,014,224,273,949 in revenue, with the lowest revenue forecast at $76,014,224,273,949 and the highest revenue forecast at $76,014,224,273,949.